| Patient | Jane Austen |
|---|---|
| Date of birth | 1985-12-16 |
| Identifiers | MRN HR-EN014-SYN; SSN (made up) 000-14-6317 |
| Document date | 2026-10-12 |
| Author | Harriet Pemberton-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Seven-month review: replacement, renin, thyroid, mood, and the closing of the differential. [S]
Ms. Austen returns seven months after diagnosis. She feels well. She writes every morning and walks several miles most days, and she has had no illness needing stress doses since the spring. She has had no fevers, night sweats or lumps. Her back has given her scarcely any pain for months. Her periods are regular. She notices that the darkness of her hands has nearly gone. She carries her kit and wears her medical ID. [S]
| Element | Detail |
|---|---|
| Replacement | Hydrocortisone 10 mg and 5 mg; fludrocortisone 0.1 mg; no missed doses |
| Symptoms | None; energy for full days |
| Weight | 57.2 kg, her usual weight |
| Mood | PHQ-9 2 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No tiredness, fevers, night sweats or weight loss |
| Cardiovascular | Negative | No lightheadedness or ankle swelling |
| Gastrointestinal | Negative | No nausea or salt craving |
| Genitourinary | Negative | Periods regular |
| Endocrine | Negative | No cold intolerance, thirst, or weight gain beyond her usual |
| Psychiatric | Negative | Mood good; PHQ-9 2 |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrocortisone 10 mg oral tablet, one tablet by mouth on waking | One tablet by mouth on waking | Oral route | 2026-03-19 | active | S |
| Hydrocortisone 5 mg oral tablet, one tablet by mouth at 2 pm | One tablet by mouth at 2 pm | Oral route | 2026-03-19 | active | S |
| Fludrocortisone 0.1 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 2026-03-19 | active | S |
| Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911 | Once, as needed for adrenal crisis; carry at all times | Intramuscular route | 2026-03-19 | active | S |
| Amoxicillin 500 mg oral capsule, one capsule by mouth twice daily for ten days | One capsule twice daily for ten days | Oral route | 2026-04-20 to 2026-04-29 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-12 | Body height | 170 | cm | S |
| 2026-10-12 | Body weight | 57.2 | kg | S |
| 2026-10-12 | Body mass index (BMI) [Ratio] | 19.8 | kg/m2 | S |
| 2026-10-12 | Systolic blood pressure | 116 | mm[Hg] | S |
| 2026-10-12 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-10-12 | Heart rate | 68 | /min | S |
| 2026-10-12 | Respiratory rate | 14 | /min | S |
| 2026-10-12 | Body temperature | 36.6 | Cel | S |
| 2026-10-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-12 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-10-12 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-10-12 | Creatinine [Mass/volume] in Serum or Plasma | 0.85 | mg/dL | 0.57-1 mg/dL | Normal | S |
| 2026-10-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 89 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-10-12 | Renin [Enzymatic activity/volume] in Plasma | 2.8 | ng/mL/h | Upright, mid-morning: 0.6 to 4.3 ng/mL/h | Normal | S |
| 2026-10-12 | Hemoglobin [Mass/volume] in Blood | 13.2 | g/dL | 12-15.5 g/dL | Normal | S |
| 2026-10-12 | Thyrotropin [Units/volume] in Serum or Plasma | 2.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-10-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S |
Vital signs recorded on 2026-10-12; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 57.2 kg, BMI 19.8 |
| Blood pressure lying and standing | 118/74 lying, 116/74 standing: no postural drop |
| Skin and mouth | Faint residual pigmentation of the palmar creases and gums; no thin skin, striae, bruising or facial rounding |
| Lymph nodes | No cervical, supraclavicular, axillary or inguinal nodes |
| Abdomen | No enlarged liver or spleen |
| Neck | Thyroid normal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| About three months of increasing tiredness, loss of 5 kg, darkening of the skin, nausea with bouts of vomiting, low back ache, salt craving and lightheadedness on standing, with low sodium, high potassium and raised eosinophils; adrenal insufficiency suspected and urgent endocrinology testing booked | resolved | confirmed | R53.83 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the consultation; its timing echoes the documented break in her health (D). |
| Primary adrenal insufficiency (Addison's disease): no cortisol response to cosyntropin with a markedly raised ACTH, and mineralocorticoid deficiency with raised renin and low aldosterone; on hydrocortisone and fludrocortisone; synthetic modern diagnosis chosen for a historical illness whose cause is disputed | active | confirmed | E27.1 | S — Synthetic modern diagnosis; the historical cause of her illness remains undetermined (R, disputed). |
| Mild normocytic anemia (hemoglobin 11.4 g/dL) with normal ferritin, vitamin B12 and folate | resolved | confirmed | D64.9 | S — Synthetic finding at intake; it recovers on replacement. |
| Group A streptococcal pharyngitis with fever, treated with amoxicillin and doubled hydrocortisone under the sick-day rules; resolved | resolved | confirmed | J02.0 | S — Synthetic intercurrent illness; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Glucocorticoid dose: weight, energy, appetite, skin pigmentation, and signs of under- or over-replacement | Every visit | Completed today | Weight 57.2 kg, her usual; energy good; no signs of excess |
| Examination | Blood pressure lying and standing | Every visit | Completed today | 118/74 lying, 116/74 standing: no postural drop |
| Laboratory | Mineralocorticoid: salt craving, edema, sodium and potassium | Before treatment, after any fludrocortisone change, then at least yearly | Completed today | Sodium 140, potassium 4.2 mmol/L; creatinine 0.85 mg/dL, eGFR 89 |
| Laboratory | Plasma renin activity (with aldosterone at diagnosis) | At diagnosis; after any fludrocortisone change; then at least yearly, aiming for the upper normal range | Completed today | 2.8 ng/mL/h, normal; next yearly |
| Self-management | Sick-day rules, emergency injection kit, steroid card, and medical ID | Every visit | Completed today | Kit in date; card and medical ID with her; rules reviewed |
| Examination | Differential for lymphoma: weight, fevers and night sweats, lymph nodes and spleen, LDH, chest X-ray | At diagnosis, then each visit until symptoms and weight have recovered on replacement | Completed today | Weight and energy fully recovered; no fevers, night sweats, nodes or enlarged spleen: lymphoma not suspected; no CT needed |
| Laboratory | Associated autoimmune disease: TSH, vitamin B12, A1c, celiac serology, and menstrual history | At diagnosis, then TSH and the others yearly or with symptoms; FSH if periods change | Completed today | TSH 2.9 mIU/L; periods regular; vitamin B12, A1c and celiac serology due at one year |
| Laboratory | Blood count for the normocytic anemia (with ferritin, vitamin B12 and folate at work-up) | Work-up at diagnosis; repeat after the underlying cause is treated (CMID); stop once normal | Completed today | Hemoglobin 13.2 g/dL, normal; no further checks needed |
| Survey | Depression screen | Yearly and when symptoms suggest | Completed today | PHQ-9 2, from 6 at diagnosis |
| Self-management | Hepatitis B vaccine | Two doses at least four weeks apart | Completed today | Dose 2 given today; series complete |
| Self-management | Influenza vaccine | Every autumn | Completed today | Given today |
| Referral | Endocrinology review | At least yearly | Due | Yearly review with Dr. Varga-Whitlock in five months |
Goal progress:
Immunizations given today: Hepatitis B vaccine (HepB-CpG), dose 2 of 2; Influenza vaccine, inactivated, this season [S]
Guideline basis: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026); American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease (2023); Depression and Suicide Risk in Adults: Screening (2023); Adult Immunization Schedule by Age (2026)
Follow-up: Endocrinology review in five months, with vitamin B12, A1c and celiac serology at one year. Primary care review every six months, with electrolytes, renin and TSH yearly. Follow the sick-day rules for any illness. [S]